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Abstract
Longitudinal studies on the course of neurocognitive functioning of children with ADHD and their unaffected siblings are scarce.
Also, it is unclear to what extent that course is related to ADHD outcomes. A carefully phenotyped large sample of 838 Caucasian
participants (ADHD-combined type: n = 339, unaffected siblings: n = 271, controls: n = 228; mean age at baseline = 11.4 years,
mean age at follow-up = 17.3 years, SD = 3.2) was used to investigate differences in the course of neurocognitive functioning of
ADHD affected and unaffected siblings versus controls, and to investigate the relationship between neurocognitive change and
ADHD outcomes. At baseline, an aggregated measure of overall neurocognitive functioning and eight neurocognitive measures
of working memory, timing (speed/variability), motor control, and intelligence were investigated. Outcomes at follow-up were
dimensional measures of ADHD symptom severity and the Kiddie-Global Assessment Scale (K-GAS) for overall functioning. At
follow up, affected and unaffected siblings trended to, or fully caught up with performance levels of controls on four (44.4%) and
five (55.6%) of the nine dependent variables, respectively. In contrast, performance in remaining key neurocognitive measures
(i.e. verbal working memory, variability in responding) remained impaired at follow-up. Change in neurocognitive functioning
was not related to ADHD outcomes. Our results question the etiological link between neurocognitive deficits and ADHD
outcomes in adolescents and young adults.
Keywords ADHD .Neurocognitive functioning . Course . Symptom severity . Overall functioning
Attention-Deficit/Hyperactivity Disorder (ADHD) is charac-
terized by impairing symptoms of inattention and/or hyperac-
tivity/impulsivity (American Psychiatric Association 2013)
that are to a large extent persistent into adolescence and young
adulthood (Franke et al. 2012; Greydanus et al. 2007; van
Lieshout et al. 2016). Although neurocognitive dysfunctions
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are at the heart of the majority of models on ADHD (Barkley
1997; Pennington and Ozonoff 1996; Sergeant 2000; Rapport
et al. 2009; Sonuga-Barke et al. 2010), little is known about
the longitudinal course of these dysfunctions and its relation to
behavioral outcomes in ADHD.
Different perspectives exist on the course of neurocognitive
functions and its relation with behavioral outcomes of ADHD
in particular. The first perspective is that of ADHD reflecting a
Bmaturational lag^, focusing on the course of neurocognitive
functions, but not its relation with behavioral outcomes:
Children with ADHD will remit from their impairments in
neurocognitive functioning and their ADHD symptoms dur-
ing development and catch-up with normative development
(Berger et al. 2013; Drechsler et al. 2005; Klein and
Mannuzza 1991; Shaw et al. 2007, 2012). Following the mat-
urational lag hypothesis, a partial or full catch-up of
neurocognitive functioning to the level of controls is expected
for all neurocognitive functions.
From the following models, hypotheses regarding the rela-
tionship between neurocognitive functioning (over time) and
(ADHD) behavior are derived. Importantly, these models are
not necessarily discrete; overlap might exist. One important
model is the endophenotype model. This model describes the
relationship between neurocognitive functioning and pheno-
typic characteristics, by stating that neurocognitive functions
mediate between the genetic liability for the disorder and the
phenotypic expression (Gottesman and Gould 2003).
Although this model not explicitly zooms in on longitudinal
aspects, according to this model, it is likely to expect that
improvements in neurocognitive functioning relate to better
behavioral outcomes and that deterioration of neurocognitive
functioning would relate to worse behavioral outcomes. An
extension is postulated by Halperin and Schulz (2006), who
specifically focused on longitudinal aspects and differentiated
between different types of neurocognitive functions. They hy-
pothesize that the normalization of functions requiring high
mental effort and/or conscious control may underlie symptom
improvement, while impairment in functions requiring lower
levels of effort and/or control may be persistent, core deficits
in ADHD, unrelated to symptom recovery (Halperin and
Schulz 2006). Following this model it is thus expected that
strong higher order neurocognitive functions are related to
better ADHD outcomes, while (some, not necessarily all) low-
er order neurocognitive functions remain impaired and are not
related to ADHD outcomes. A contrasting model is that
neurocognitive dysfunctions have no etiological role in
ADHD. They can at best be seen as some type of comorbid
condition, related to the same underpinnings as ADHD symp-
toms, but not necessarily causally related. Presence of co-
occurring neurocognitive problems then may mark a more
severe form of the disorder as neurocognitive deficits and
symptoms may independently contribute to impairment
(Coghill et al. 2014a; van der Meer et al. 2013). According
to this model, longitudinal change in neurocognitive function-
ing is causally unrelated to ADHD outcomes. An extension to
this model is a phenomenon called Berkson’s bias (Peritz
1984): possibly, only children with ADHD symptoms and
neurocognitive dysfunctions are clinically referred (because
they are more severely impaired), while children with symp-
toms without neurocognitive dysfunctions may be ‘missed’.
This may lead to a distorted view on the role of neurocognitive
dysfunctioning in ADHD. A case of Berkson’s bias should
thus be considered when there is a longitudinal relationship
between neurocognitive functioning and overall functioning.
In summary, there is an ongoing debate on the role of (the
longitudinal course of) neurocognitive functioning in the
emergence and further course of ADHD.
Both cross-sectional and longitudinal studies have investi-
gated the relationship between neurocognitive functioning
and ADHD. Although a longitudinal approach can provide
us with more insight into the possible causal role of
neurocognitive functioning for ADHD outcome, studies using
such a design are in a minority. Cross-sectional studies per-
formed so far suggest that at least three major domains seem to
play a key role in ADHD: cognitive control, reward process-
ing, and temporal processing (Castellanos and Tannock 2002;
Durston et al. 2011; Sonuga-Barke et al. 2010;Wahlstedt et al.
2009), although, for example, also processing speed and mo-
tor control appear relevant (Faraone et al. 2015). Longitudinal
studies investigating possible causal relations between
neurocognitive functioning and ADHD outcome show hetero-
geneous results: Several longitudinal studies that looked into
the predictive value of neurocognitive deficits in preschool
children showed that early neurocognitive deficits predicted
the onset of ADHD in (younger) childhood (Pauli-Pott and
Becker 2011; Rajendran et al. 2013a, b; van Lieshout et al.
2013) or ADHD symptoms in adolescence (Sjöwall et al.
2015). For example, it was recently demonstrated that
neurocognitive deficits at age 3–4 years had an overall predic-
tive power of 67% for the emergence of ADHD at age 6 years
in children with behavioral problems (e.g. high activity level,
defiance, aggression or impulse control (Breaux et al. 2016).
In addition, some studies investigated the course of
neurocognitive functioning in relation to ADHD outcomes
and found support for earlier mentioned theories in which
neurocognitive improvement was related to better ADHD out-
comes (Biederman et al. 2009; Coghill et al. 2014a, b;
Michelini et al. 2016; Miller et al. 2013; Rajendran et al.
2013a, b). However, several (other) studies (also) indicated
limited predictive value of the course of neurocognitive func-
tions from childhood to adolescence/young adulthood for
ADHD outcomes; in these studies, the course of
neurocognitive functioning was (largely) independent of the
course of diagnostic status or symptoms (Coghill et al. 2014a,
b; McAuley et al. 2014; van Lieshout et al. 2013). Taken
together, existing studies show little convergence on the exact
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relationship between the course of neurocognitive functioning
and ADHD outcomes in adolescence/young adulthood and
findings do not suggest that there is evidence of specific
neurocognitive functions that relate more strongly than others
to ADHD symptom development (onset or persistence).
The inconsistent findings of previous studies examining lon-
gitudinal relationships between neurocognitive functions and
ADHD may be related to methodological shortcomings (see
for systematic review: van Lieshout et al. 2013). A first general
issue is that sample sizeswere often quite small, whichmay have
led to statistical power problems, more specifically an increased
risk of type II errors; failing to detect an effect that actually is
present. Second, some aspects hindered clear interpretation re-
garding the role of neurocognitive change for ADHD outcomes:
(a) only few studies actually did include neurocognitive mea-
surements at two time points or more. (b) Studiesmainly focused
only on one specific aspect of neurocognitive functioning, while
it is likely that multiple domains may be involved in the relation-
ship between neurocognitive functioning and ADHD outcomes.
A third limitation relates to the type of outcome measures: (a)
most of the studies focused on diagnostic outcomes, rather than
on (more sensitive) continuous measures of symptom severity
(Willcutt et al. 2012; Lahey andWillcutt 2010), which may have
led to an underestimation of apparent relationships between
neurocognitive functioning and behavioral problems. (b) Few
studies targeted outcomes other than ADHD, such as overall
functioning, covering aspects of social, psychological, and aca-
demic functioning. Such outcomes may clinically be more rele-
vant. Fourth, some issues relate to the investigation of potential
confounding or moderating effects: (a) most of the studies so far
did not investigate possible moderating effects of age in samples
with a large age range. Investigating age is highly relevant given
the ongoing neurocognitive and behavioral development from
childhood into adulthood, for which some functions show a
sharp transition in adolescence (Geier 2013). Further, the course
of neurocognitive functioning over age may even show a non-
linear pattern (Vaughn et al. 2011). (b) Few studies took effects
of medication history into account, which is of importance, as
pharmacological treatment may impact behavioral outcomes
(Faraone andBuitelaar 2010) as well as neurocognitive function-
ing (Coghill et al. 2014a, b). Taken together, many limitations of
previous studies may explain inconsistencies in findings current-
ly available.
An important group in understanding the course of ADHD
is the group of unaffected siblings of children with ADHD.
Because affected siblings share on average one-half of their
genetic variants and several environmental risk factors with
their unaffected sibling (some of whom have subclinical levels
of ADHD symptoms), these unaffected siblings may be at-risk
for developing a full diagnosis. However, in unaffected sib-
lings, developmental outcomes can be studied independent of
an ADHD diagnosis and treatment for ADHD at study entry.
To our knowledge, unaffected siblings have not yet been
studied longitudinally in relation to neurocognitive function-
ing. Cross-sectional studies of neurocognitive functioning in
unaffected siblings showed mixed results: Unaffected siblings
showing worse performance than controls (Rommelse et al.
2007a), with unaffected siblings not being different from their
ADHD siblings (Bidwell et al. 2007; Pironti et al. 2014), or
showing scores in between affected siblings and controls
(Rommelse et al. 2008a, b), or showing subtle or even no
deficits, while their affected siblings were impaired (Doyle
et al. 2005; Fliers et al. 2010; Rommelse et al. 2008b,
2007a; Seidman et al. 2000).
The current study improves upon shortcomings of earlier
studies, by prospectively studying a large sample of extensively
phenotyped ADHD affected and unaffected siblings, and con-
trols (N = 838). We investigated the neurocognitive course of
these three groups of children to achieve two aims. First, we
investigated the neurocognitive course in multiple domains (an
aggregated measure of neurocognitive functioning, working
memory, timing, variability, baseline speed, motor control, and
IQ) comparing ADHD affected and unaffected siblings with
controls. Participants were between 5 and 19 years old at base-
line and re-assessed on average six years later when they were
between 11 and 25 years old. Second, we mapped the course of
neurocognitive functioning in multiple domains onto dimen-
sional ADHD outcomes (symptoms and functional outcome)
at follow-up, over and above baseline ADHD severity, carefully
taking into account the effects of age. As several theoretical
models exist on the course of neurocognitive functioning and
its relationship with ADHD outcomes, and these models formu-
late contrasting ideas, we did not formulate hypotheses. Rather,
we discussed which model(s) best fitted our results.
Method
Participants
A sample of 838 participants with ADHD combined type
(ADHD/C; affected siblings), their unaffected siblings, and con-
trols, aged 5 to 19 years at baseline, participated in this study.
The sample was part of a follow-up study of theDutch branch of
the International Multicenter ADHD Genetics (IMAGE) study
(von Rhein et al. 2015). The original sample (N = 1092) was
contacted and invited for follow-up on average 5.9 years (SD =
0.8) after enrolment; 76.7% (N = 838) was retained successfully.
Attrition analyses are described in Supplement 1.
Selection and diagnostic procedures at baseline (Müller et al.
2011) and at follow-up (von Rhein et al. 2015) have been de-
tailed previously. Briefly, inclusion criteria for entry at baseline
were an age of 5–19 years, Caucasian descent, IQ ≥ 70, no di-
agnosis of autism, epilepsy, general learning difficulties, brain
disorders, and known genetic disorders. Inclusion criteria for the
ADHD group were a (suspected) clinical diagnosis of ADHD/C
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as established by a registered health care professional confirmed
using an extensive assessment protocol at baseline. Please see
Supplement 1 for a more detailed description on selection and
diagnostic procedures, as well as additional exclusion criteria
regarding the data quality check. At baseline, all participants
diagnosed with ADHD/C had at least six symptoms in both
the inattention and hyperactive/impulsive domains endorsed
on the Parental Account of Children’s Symptoms (PACS;
Taylor 1986) in combination with a teacher rating and additional
check of criteria such as impairment and pervasiveness.
Definition of affected and unaffected siblings refers to the diag-
nostic status at baseline. See Supplement 1 for further details on
participant inclusion. The 838 participants came from 398 dif-
ferent families. Included were 339 participants with ADHD/C
(mean age at baseline = 11.4 years, SD = 2.8; range: 5.4–18.0,
and mean age at follow-up = 17.5 years, 82.0% males); 271
unaffected siblings (mean age at baseline = 11.2 years, SD =
3.6; range: 5.2–18.5, and mean age at follow-up = 17.3 years;
41.3% males), and 228 controls (mean age at baseline =
11.6 years, SD = 3.2; range: 5.2–19.0, and mean age at follow-
up = 16.8 years; 39.9% males).
Measures
Neurocognitive Variables Neurocognitive variables were iden-
tically measured at baseline and at follow-up. Measures were
chosen at the time of baseline assessment based on their poten-
tial to discriminate between ADHD and control and in addition,
their potential to act as endophenotype (e.g. associated with
unaffected siblings). Included were verbal working memory
(Rommelse et al. 2008a), temporal processing (time
production, time reproduction, time production variability, and
reaction time variability; Rommelse et al. 2008b, 2007a; Tamm
et al. 2012; Toplak et al. 2006; Willcutt et al. 2012), reaction
time speed (Rommelse et al. 2008b; Willcutt et al. 2012), motor
control (Carte et al. 1996; Pitcher et al. 2002; Rommelse et al.
2007b), and intelligence (Frazier et al. 2004; Rommelse et al.
2008a; Willcutt et al. 2012). Although we have included mea-
sures for inhibition and visuo-spatial working memory at base-
line and follow-up, we could not include these measures in the
current manuscript, given that these measures were adjusted for
use in the MRI scanner at follow-up. For an index of overall
neurocognitive functioning an aggregated score including all
neurocognitive measures described above was used. All vari-
ables were standardized into z-scores, by pooling data for the
two time points and three groups, except for the variable total
IQ, which was already expressed in age-adjusted normalized
scores. See for further details on paradigms that were used
Supplement 1 and Supplemental Table 1.
Outcome MeasuresADHD symptom severity at follow-up was
our main dependent variable assessed as the raw score on the
Conners’ Parent Rating Scale–Revised: Long version (CPRS-
R:L; Conners et al. 1998) scale N, hereafter referred to as ‘cur-
rent ADHD symptoms’. Scores on the Conners ADHD sub-
scales represent combined measures of the number and severity
of symptoms. The Global Assessment Scale-score (K-GAS) of
the Dutch version of the Schedule for Affective Disorders and
Schizophrenia for School-Age Children - Present and Lifetime
Version (K-SADS;Kaufman et al. 1997) administered at follow-
up to both the parent and the child ≥12 years separately, was
used to measure current overall functioning. As part of the K-
SADS interview, the interviewer rated psychological, social and
academic functioning, resulting in an overall measure of the
current level of functioning ranging between 1 (worst possible
level of functioning) and 9 (best possible level of functioning)
(please see Schorre and Vandvik 2004 for similar scoring
systems). Interviewers from the participating centers (clinicians
- i.e. child psychiatrists, psychologists-, or researchers - having a
minimal degree of MSc) underwent comprehensive training by
a team under the supervision of JB at the Donders Institute for
Brain, Cognition and Behavior, Radboud University Medical
Center, Nijmegen. Trained interviewers used the same training
and supervision procedures for additional interviewers at the
participating centers. Inter-rater agreement on diagnoses (K-
SADS) was 0.94 (Cohen’s kappa, ADHD; von Rhein et al.
2015).
Covariates Follow-up interval was defined as the time between
baseline and follow-up measurement (in years). Baseline
ADHD symptom severity was measured by scale N of the
CPRS-R:L, and impairment at baseline was measured by the
impairment scale of the Strengths and Difficulties
Questionnaires (SDQ; Goodman, 1997), reported by parents
(range 0–21). Pharmacological treatment of ADHDwas defined
as the cumulative intake of psychostimulants from age of onset
until follow-up. Information on cumulative intake (mean daily
dose multiplied by treatment duration corrected for age (treat-
ment duration in months divided by [age minus the minimum
start-age within the sample, i.e., 28 months])) was derived from
pharmacy transcripts, and when pharmacy transcripts did not
fully cover the self-reported treatment period, medication pa-
rameters of the missing period(s) were calculated from question-
naire data and were added to the measures derived from the
pharmacy, see for a full description (van Lieshout et al. 2016).
Age was measured as age at follow-up, in years. Sex and study
site (Amsterdam/Nijmegen) were also included as covariates.
See for a description of predictor and outcome variables Table 1.
Procedure
Testing at baseline and follow-up took place at the Vrije
Universiteit Amsterdam, or at the Donders Institute in
Nijmegen, the Netherlands. Participants were ≥ 48 h off med-
ication during both baseline and follow-up assessments
allowing complete wash-out (Greenhill et al. 2002). All
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ratings of behavioral functioning pertained to the participant’s
functioning off medication. Families were financially com-
pensated for participation. Informed consent was signed by
all participants at both measurements, and parents signed for
all children in their family as well. Ethical approval was ob-
tained (CMO Regio Arnhem-Nijmegen; 2008/163; ABR:
NL23894.091.08).
Statistical Analysis
The Course of Neurocognitive Functioning A linear mixed
model was used to compare the course of neurocognitive
functioning over the six year follow-up period of (1a) affected
siblings (AS) versus controls, and (1b) unaffected siblings
(US) versus controls. For all neurocognitive measures, we
tested a group-by-time (baseline to follow-up) interaction-
effect using a full-factorial model. In all models, family and
subject were tested as random effects to account for within
family correlation and for correlated measurements over time.
Group was used as a fixed factor, and time as a repeated
measure. Significance thresholds were set at 0.05. Please see
for specific details regarding data preparation Supplement 1.
Covariates In all analyses age at baseline and follow-up inter-
val were included as covariates by default. Further, it was
checked whether sex, pharmacological treatment, study site
and the group-by-follow-up interval interaction effect con-
founded our findings, by adding these variables to the signif-
icant models.
Moderating Effects of Age To explore potentially moderating
effects of age, for all significant group-by-time interaction
effects we tested the group-by-time (baseline to follow-up)-
by-age (at baseline) interactions with a similar analytic proce-
dure as described above. When significant, we retested the
group-by-time effect in three equal sized age groups, to ex-
plore at which age catch-up has taken place.
Predicting ADHD Outcome from Neurocognitive Change To
investigate whether the course of neurocognitive functioning
was related to ADHD outcomes (ADHD symptom severity
and overall functioning) in affected and unaffected siblings,
linear mixed models were used to account for familial depen-
dence, with family as random effect . Change in
neurocognitive performance between follow-up and baseline






M SD M SD M SD M SD M SD M SD
Age (yrs) 11.44 2.77 11.21 3.57 11.60 3.22 17.51 2.80 17.30 3.62 16.85 3.22
Sex (N, % male) 278 82.0% 112 41.3% 91 39.9% – – – – – –
Follow-up interval – – – – – – 6.07 0.64 6.09 0.61 5.25 0.72
Pharmacological treatment until
follow-up (cumulative intake)
– – – – – – 126.96 121.08 21.75 65.91 0.10 1.31
SDQ impairment (parent) 12.40 3.88 3.02 4.48 n.a. n.a. – – – – – –
CPRS-R:L total symptom severity (scale N) 35.64 8.59 8.52 8.92 4.67 4.42 23.21 11.42 7.71 8.82 4.02 4.80
K-GAS-score n.a. n.a. n.a. n.a. n.a. n.a. 6.42 1.13 7.93 1.19 8.52 1.16
Overall measure of neurocognitive functioning −0.40 0.79 −0.39 0.83 −0.18 0.66 0.28 0.43 0.25 0.41 0.32 0.34
Maximum span Digit Span backwards
WISC/WAIS
3.79 1.12 4.00 1.22 4.41 1.31 4.25 1.20 4.60 1.23 4.89 1.29
Absolute deviation of median production
Motor Timing Task (ms)
96.34 90.94 102.44 106.64 98.62 84.87 80.53 72.89 74.38 66.44 66.44 58.55
Percentage of deviation Time Test (ms) 21.46 14.32 19.85 16.46 13.77 8.63 14.09 8.85 12.90 7.33 11.12 5.94
SDRTa ANT Baseline Speed (ms) 0.36 0.23 0.35 0.23 0.32 0.21 0.30 0.17 0.28 0.15 0.25 0.13
SDRTa Motor Timing Task (ms) 0.37 0.29 0.35 0.33 0.27 0.20 0.22 0.08 0.20 0.07 0.18 0.05
RTANT Baseline Speed (ms) 361.70 87.33 374.26 111.25 353.10 84.83 268.97 38.08 269.06 41.33 260.38 34.28
Mean absolute deviation ANT Tracking Task
(mm)
2.93 2.09 2.34 1.56 1.99 1.60 2.56 1.48 2.35 1.14 2.15 1.15
Total IQ WISC/WAIS 95.44 14.85 101.73 12.97 105.59 13.21 94.77 16.27 100.96 15.17 106.72 14.19
Groups (ADHD/C, unaffected siblings and controls) were defined at baseline
ADHD, Attention-Deficit/Hyperactivity Disorder; ANT, Amsterdamse Neuropsychologische Taken; CPRS-R:L, Conners’ Parent Rating Scale-Revised:
Long Version; K-GAS, Kiddie-Global Assessment Score; RT, Reaction time; SDRT, Standard deviation of reaction time; SDQ, Strengths and Difficulties
Questionnaire; WAIS, Wechsler Adult Intelligence Scale; WISC, Wechsler Intelligence Scale for Children
a Corrected for mean reaction time
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was calculated for each neurocognitive measure separately
and used as fixed predictor in the analyses, while follow-up
measures of ADHD symptom severity and overall functioning
were used as outcome measures. For the time production mea-
sure, the statistical analysis differed slightly compared to that
of the other variables, see Supplement 1.
Covariates As there is a strong relationship between baseline
and follow-up measures of symptom severity and impairment
respectively, the baseline measures were fixed covariates in
the respective mixed model-analyses. Age at baseline and
follow-up interval were included as covariates by default.
Further, when there were significant moderating effects be-
tween change in neurocognitive performance and age (or
group; affected, unaffected siblings) on ADHD outcomes,
we added the significant interaction effect to the main analysis
investigating the relationship between neurocognitive change
and outcome measures to account for differential age or group
effects. Further, for our main analyses it was checked whether
sex, pharmacological treatment, and study site confounded
our results, by adding these variables to the significant
models.
Sensitivity AnalysesAs the results may have been impacted by
including children with an IQ < 80, we checked whether re-
sults of our main analyses were robust when tested in a sample
of children with an IQ ≥ 80.
Results
Data quality check revealed that for included participants,
0.0%–1.4% of data per measure needed to be excludedmainly
as a result of extreme outliers. As linear mixed models were
used, these missing data points were taken into account by
way of maximum likelihood estimation.
The Course of Neurocognitive Functioning
Table 2 displays the group-by-time interaction effects on
neurocognitive development from baseline to follow-up, as well
as the main effects of group. Figure 1a, b show the estimated
plots for our aggregatedmeasure of overall neurocognitive func-
tioning, based on the individual slopes. Figure 1a illustrates that
for overall neurocognitive functioning US and AS show a
Table 2 Summary of statistical parameters in ADHD affected and unaffected siblings compared to controls





b SE p b SE p F p Contrastsb
Overall neurocognitive functioning Group x time −0.18 0.06 0.01 −0.15 0.07 0.02
Group 2.063 0.16
Verbal working memory Group x time 0.01 0.10 0.95 −0.12 0.11 0.25
Group 20.135 < 0.001 0 > 1 > 2
Time production Group x time −0.21 0.12 0.09 −0.28 0.14 0.046
Groupc 4.333 0.01 0 = 1,2; 1 > 2
Time reproduction Group x time −0.44 0.10 < 0.001 −0.38 0.11 0.001
Groupd 12.122 < 0.001 0 > 1 > 2
Reaction time variability Group x time 0.05 0.12 0.67 0.001 0.13 0.96
Groupe 8.163 < 0.001 0 > 1 > 2
Time production variability Group x time −0.27 0.11 0.01 −0.26 0.12 0.03
Group 28.663 < 0.001 0 > 1 > 2
Reaction time speed Group x time −0.002 0.08 0.98 −0.13 0.10 0.19
Group 6.115 0.002 0 > 1 = 2
Motor control Group x time −0.34 0.12 0.01 −0.10 0.12 0.40
Groupf 1.217 0.30
Intelligence Group x time 0.12 0.07 0.10 0.14 0.07 0.054
Group 27.194 < 0.001 0 > 1 > 2
Symbols that were provided in bold indicate a p-value < 0.05
0, Controls; 1, Unaffected siblings; 2, Affected siblings; ADHD, Attention-Deficit/Hyperactivity Disorder
a Group x time interaction effects and main effects of group at follow-up were tested in separate analyses. b Based on mirrored z-scores, higher scores
indicate better performance. c Sex and studysite were added as additional relevant confounders. d Sex was added as an additional relevant confounder. e
Studysite was added as an additional relevant confounder. f Sex and pharmacological treatment were added as additional relevant confounders
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pattern of catch-up compared to controls (group x time interac-
tion for AS vs controls: b = −0.18, p= 0.005; and US vs con-
trols: b = −0.15, p = 0.024). Analysis on single measures of
neurocognitive functioning also showed this pattern of catch-
up indicated by a significant group x time interaction for time
production (US vs controls: b = −0.28, p = 0.048), time repro-
duction (AS vs controls: b = −0.44, p < 0.001; US vs controls:
b = −0.38, p = 0.001), time production variability (AS vs con-
trols: b = −0.27, p = 0.01; US vs controls: b = −0.26, p= 0.03),
and motor control (AS vs controls: b = −0.34, p = 0.008). For
time production, unaffected siblings showed a stable pattern of
slight underestimation of the 1000 ms interval over time, while
controls showed overestimation of the 1000 ms interval at base-
line and reached the level of (underestimation of) unaffected
siblings at follow-up. For the remaining neurocognitive func-
tions (US and AS: verbal working memory, reaction time vari-
ability, reaction time speed, intelligence; AS only: time produc-
tion; US only: motor control), the group x time interaction was
not significant. Post hoc analysis showed that for overall
neurocognitive functioning, time production and motor control,
there was no significant main effect of diagnostic group at
follow-up (all p-values >0.093), indicating that full catch-up
had taken place. For the other measures, a main effect of diag-
nostic group was found (all p-values <0.002; time production
variability US vs controls: d = 0.46, AS vs controls: d = 0.67;
time reproduction US vs controls: d = 0.30, AS vs controls: d =
0.39), indicating that although affected and/or unaffected sib-
lings showed a pattern of catch-up and trended to performance
levels of controls, for these measures, performance levels
remained behind the level of controls at follow-up.
Covariates Analysis of the possible confounders revealed that
sex significantly impacted on the two-way interaction model of
time reproduction comparing unaffected siblings with controls
(p = 0.003), however, when including sex in the model, the
group x time interaction effect remained significant (p =
0.001). Group interacted significantly with follow-up interval
in the two-way interaction model of time production comparing
unaffected siblings with controls (p = 0.028), however, when
including the group x follow-up interval interaction effect in
the model, the group x time interaction remained significant
(p = 0.048). None of the other potentially confounding relation-
ships were significant (p-values between 0.13 and 0.99).
Moderating Effects of Age To explore possible moderating
effects of age on the course of neurocognitive functioning
for the three diagnostic groups, group x time x age interactions
were tested. The group x time x age interaction was significant
for time production variability (AS vs controls: b = 0.13, p <
0.001; US vs controls: b = 0.11, p = 0.002), and time repro-
duction (AS vs controls: b = 0.07, p = 0.03). See Figs. 1 and 2
for visual plots. Further analysis in three equal sized age
groups (ages 5–9.8 years; ages 9.8–12.9 years; ages 12.9–
19 years) revealed that for time production variability (both
AS and US) and time reproduction (AS), the group x time
interaction effect was significant only in the youngest age
group (p < 0.007).
Predicting ADHD Outcome from Neurocognitive
Change
Table 3 displays results of the relationship between
neurocognitive change and both ADHD symptom severity
and impairment at follow-up, over and above baseline
ADHD symptom severity and impairment, respectively.
Time production (higher score, less time-underproduction) at
follow-up, adjusted for time production at baseline, was relat-
ed to higher overall functioning at follow-up (b = 0.15, p =
0.001). No further significant relationships between
neurocognitive change and either symptom severity or overall
functioning at follow-up were observed (all p-values >0.07).
Covariates Group interacted significantly with the predictive
effects of change in time reproduction on overall functioning
(p = 0.04) and therefore was taken into account as a covariate
in all analyses on time reproduction and overall functioning.
Both group (all p-values >0.13) and age (all p-values >0.06)
did not significantly interact with neurocognitive change, in-
dicating that relationships between neurocognitive change and
outcomes were neither dependent on group (affected, unaf-
fected siblings) nor on age. Analysis of the other possible
confounders revealed that pharmacological treatment signifi-
cantly impacted on the model of time production (p = 0.023),
leaving the significant relationship between time production
and overall functioning intact (p = 0.003). None of the other
potentially confounding relationships were significant (p--
values between 0.054 and 0.84).
Sensitivity Analyses
Findings on the main analyses regarding the course of
neurocognitive functioning and regarding the prediction of
ADHD outcome using neurocognitive change replicated
when participants with an IQ < 80 (n = 19) were excluded
from the analyses. Similar or comparable (non-)significance
levels and effect sizes were obtained.
Discussion
Despite the central role of neurocognitive impairment in etio-
logical models of ADHD, little is known about the longitudi-
nal course of these neurocognitive characteristics and their
relationship with outcomes of ADHD symptoms and overall
functioning. The current study is the first to report on this in
ADHD affected (n = 339) and unaffected siblings (n = 271),
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and controls (n = 228) in childhood/adolescence. In summary,
over time, approximately half of the neurocognitive functions
in affected and unaffected siblings trended near the level of
controls (aggregated measure of overall neurocognitive func-
tioning, time production- and reproduction, time production
variability, reaction time speed, and/or motor control).
However, within this trending pattern, only for time produc-
tion, motor control, and overall neurocognitive functioning
full catch-up took place, while for the other functions, there
still was some difference in performance at follow-up between
the groups. For verbal working memory, reaction time vari-
ability, and intelligence, the initial gap between performance
of affected and unaffected siblings with controls remained
stable over a 6-year period showing similar improvement over
time. Importantly, in general, the course of neurocognitive
functioning was not related to ADHD outcomes over and
above baseline symptom severity or overall functioning in
(un)affected siblings, suggesting that improvement/ deteriora-
tion of neurocognitive performance does not translate one-to-
one into (ADHD) behavior.
In first instance, our finding that for approximately half of
our measures both affected and unaffected siblings trended to
the level of controls at follow-up, seems to fit the maturational
lag theory. This process of normalization is in line with several
previous studies that measured inhibitory control (Drechsler et
al. 2005), response variability (using the stop-task; McAuley
et al. 2014), a global measure of executive functioning, and
attention (Miller et al. 2013). However, our findings indicate
that for some functions that show a trend towards normaliza-
tion, ADHD siblings still lag behind controls. Possibly, our
sample may have been too young to show full catch-up.
However, studies in adults show otherwise (Hervey et al.
2004; Mostert et al. 2015). Another puzzling part is that fol-
lowing the maturational delay hypothesis, catch-up of
(un)affected siblings with levels of controls should be seen
at a specific age, i.e. a specific age-related ‘growth spurth’,
probably in late childhood/early adolescence with its major
changes in brain development that parallel cognitive matura-
tion (Giedd et al. 1999). However, only in three out of eigh-
teen comparisons, trending of neurocognitive functioning in
the direction of controls was dependent on age showing that
the catch-up started already in (younger) childhood, with un-
affected siblings reaching the level of controls somewhat ear-
lier than affected siblings. Taken together, findings show
greater complexity than expected based on the maturational
delay hypothesis.
Notably, verbal working memory, reaction time variability,
and intelligence did not show a trend into the direction of
performance levels of controls at all, neither in affected nor
in unaffected siblings. This is consistent with other studies on
verbal working memory, reaction time variability, and intelli-
gence (Biederman et al. 2009, 2008; Drechsler et al. 2005;
McAuley et al. 2014; Miller et al. 2012, 2013; Vaughn et al.
2011), and confirmed in adults by meta-analyses (Hervey et
al. 2004; Mostert et al. 2015). Indeed, numerous studies show
that these neurocognitive impairments are key in ADHD
(Castellanos and Tannock 2002; Martinussen et al. 2005;
Tamm et al. 2012) and our finding that these functions remain
impaired over time strengthens the proposed key role. In ad-
dition, findings do not show an evident pattern regarding to
the type of measure that remains impaired or normalizes, as
both ‘motor’ (reaction time variability) and ‘cognitive’ func-
tions (verbal working memory, intelligence) were found to
remain impaired or (partially) caught up. Clearly, our results
emphasize there is no simple relationship between
neurocognitive development and ADHD outcomes, and also
suggest that ADHD is characterized by more than a matura-
tional lag in neurocognitive functioning.
The lack of association between the course of neurocognitive
functioning and ADHD outcomes, even without correction for
multiple testing, is consistent with studies showing that the
course of different types of neurocognitive functions from child-
hood to young adulthood is largely independent of current di-
agnostic status or ADHD symptom change (Coghill et al.
2014a, b; Drechsler et al. 2005; McAuley et al. 2014; Miller et
al. 2012; van Lieshout et al. 2013). Studies that showed (at least
some) positive relation between neurocognitive improvement
and ADHD outcomes differed from our study by investigating
a preschool sample (Rajendran et al. 2013a, b); by studying
different cognitive processes (e.g. delayed matching to sample;
Coghill et al. 2014a, b); or by investigating girls only (Miller et
al. 2013). Regarding our positive finding for time production,
we should take into account the possibility of a type I error.
However, it is possible that time production ability may be a
relevant measure for every day functioning, such as planning
(Allman and Meck 2012), which may impact, for example, on
the ability to be ready on time, to cook, or to evaluate the feasi-
bility of a certain time schedule. If so, this measure may more
directly relate to overall functioning than to symptoms of
ADHD itself. Taken together, it may be concluded that the re-
lation between neurocognition and expression of the ADHD
phenotype over time is not as straightforward as was commonly
thought.
The remarkable absence of a relationship between change
in neurocognitive functioning and symptoms of ADHD, nei-
ther in affected nor their unaffected siblings leads us to suggest
this best fits a model in which neurocognitive deficits are not
Fig. 1 a Individual slopes of the overall measure of neurocognitive
functioning over two timepoints (mean follow-up interval 6.0 years), as
a function of age. b-j Estimated plots (Loess curve) based on the individ-
ual slopes (as an example plotted in Fig. 1a, for the overall measure of
neurocognitive functioning). Dotted lines represent the 95% confidence
interval. ADHD = Attention-Deficit/Hyperactivity Disorder; C =
Controls; RT = Reaction time; SD = SD in ms, divided by the mean
reaction time; SDRT = SD of mean reaction time in ms, divided by the
mean reaction time; US = unaffected siblings
b
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directly related to ADHD symptoms, i.e. do not lie in the caus-
ative chain, as was commonly thought. Our findings thus might
best fit an epiphenomenal model, in which neurocognitive dys-
functions in ADHD are seen as some form of comorbid condi-
tion, perhaps relating to the same underpinnings as ADHD
symptoms, but not mediating this relationship (Coghill et al.
2014a; van der van der Meer et al. 2013). This is in line with
other studies that for example showed that persistent genetic
factors underlie the longitudinal relationship between ADHD
and intelligence in twins (Rommel et al. 2015), or found shared
genetic etiology between several neurocognitive functions (e.g.
memory, reaction time speed, reasoning abilities), and psychiat-
ric symptoms (Hagenaars et al. 2016).
However, it may be premature to firmly conclude that
neurocognitive functions are not (at all) causally related to
the disorder. For example, the domain of executive function-
ing includes more functions beside verbal working memory,
e.g. visuo-spatial working memory, inhibitory control, set
shifting. Also, other executive functioning paradigms (for ex-
ample tasks with greater trial numbers, or tasks placing greater
demand on central executive functioning) may have been bet-
ter able tomeasure verbal workingmemory abilities compared
to the Digit Span task used in the current study (Kasper et al.
2012; Tarle et al. 2017). Further, there are neurocognitive
functions that have not been measured in the current study,
such asmotivation or reward related neurocognitive functions.
Nevertheless, the results in this large sample are very consis-
tent regarding the absent relationship between neurocognitive
functioning and ADHD outcomes. Although we consider it
unlikely that adding one or two domains or changing the type
of measures will lead to convincing and strong relationships
between neurocognitive functioning and ADHD outcomes,
further study is needed to support or nuance the current con-
clusion. Related to this point is that it has been demonstrated
that methodological variability may explicate inconsistencies
in findings (see for example Alderson et al. 2013 for factors
Fig. 1 (continued)
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that may explain inconsistencies regarding the relationship
between working memory and ADHD). Therefore, we think
it may be important to further explore other approaches. For
example, a person-based approach may reveal new insights,
acknowledging the complex interplay (e.g. strengths and
weaknesses) between neurocognitive functions within one in-
dividual as well as neurocognitive heterogeneity that may ex-
ist in the ADHD population; such studies are not often
performed yet (see for example Bergwerff et al. 2017; Fair
et al. 2012; Rommelse et al. 2016). In addition, recent studies
have shown the validity of a general continuous psychopathol-
ogy factor (so-called ‘P factor’) as an alternative approach for
the DSM-based classifications of mental disorders. Possibly,
this dimensional cross-cutting of psychopathology may be a
valuable transdiagnostic approach (Caspi et al. 2014;Martel et
al. 2016), that may increase the value of neurocognitive





















Fig. 2 The course of time production variability and time reproduction (two timepoints, mean follow-up interval 6.0 years), separated for three age
groups. SD = SD in ms, divided by the mean reaction time. a Based on mirrored z-scores, higher scores indicate better performance






ADHD symptom severity Overall functioning
Predictor (standardized change scores) b SE p b SE p
Overall neurocognitive functioning −0.05 0.04 0.22 −0.04 0.04 0.92
Verbal working memory 0.02 0.03 0.50 0.04 0.04 0.23
Time production (follow-up score)a −0.02 0.04 0.55 0.15 0.04 0.001
Time reproductionb −0.03 0.03 0.29 0.06 0.04 0.92
Reaction time variability −0.002 0.03 0.94 −0.02 0.03 0.48
Time production variability −0.03 0.03 0.22 −0.01 0.03 0.66
Reaction time speed −0.03 0.05 0.50 −0.03 0.05 0.55
Motor control 0.01 0.03 0.68 −0.06 0.03 0.07
Intelligence 0.002 0.003 0.94 0.001 0.003 0.80
All models are adjusted for baseline age, follow-up interval and baseline symptom severity/parent reported
impairment respectively. ADHD=Attention-Deficit/Hyperactivity Disorder
a Baseline time reproduction score were included in the models. b The interaction between group and time
reproduction was included in the model for overall functioning
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functions on predicting behavior beyond the narrow-defined
DSM-based categories or symptoms of ADHD, thereby ac-
knowledging commonly existent comorbidities. Another hy-
pothesis, based on studies showing that neurocognitive function-
ing is related to ADHD outcome especially in younger children
(Pauli-Pott and Becker 2011; Rajendran et al. 2013a, b; Sjöwall
et al. 2015; van Lieshout et al. 2013), is that neurocognitive
functions may be involved in the onset of ADHD, but not in
the further course of ADHD (e.g. persistence/remittance).
Perhaps in younger years, neurodevelopmental factors have
a larger impact (for example it may be possible that great-
er brain plasticity at a younger age leads to more forceful
compensating mechanisms for negative environmental
and/or biological [e.g. injury] impact), while during de-
velopment environmental factors may play an increasing-
ly greater role (e.g. parenting styles, peer relationships,
school performance/failure, self-esteem; Sonuga-Barke
and Halperin 2010). This may suggest that remittance of
ADHD is far more difficult to predict and may be impact-
ed by many more and other variables compared to the
early onset of ADHD.
The results should be viewed in the light of some strengths
and limitations. As outlined above, this is the first study to
investigate the course of neurocognitive functioning in rela-
tion to ADHD outcomes at two timepoints, including several
neurocognitive functions and continuous outcome measures -
containing overall functioning as well -, thereby taking into
account the role of age and pharmacological treatment, in a
large sample. In terms of limitations, some aspects of our
sample limit generalization to the (ADHD) population, includ-
ing our exclusive focus on individuals with the combined type
of ADHD (Lara et al. 2009), the limited representation of girls
in our sample – although models did not change when taking
sex into account -, and the inclusion of only Caucasian partic-
ipants. For reasons of feasibility, we included single measures
of multiple neurocognitive domains instead of using multiple
measures of one single domain, which would have increased
reliability of our measurements of the neurocognitive do-
mains. However, in line with our current findings, we did
not find strong and convincing relationships between
neurocognitive functioning and ADHD outcomes in an earlier
study that used multiple assessments for one neurocognitive
construct (van Lieshout et al. 2017), considering it unlikely
that this may have impacted our results. Also, the use of a
single item rating scale as an index of overall functioning is
limited andmay have precluded the possibility to detect mean-
ingful relationships between neurocognitive functioning and
specific domains of impairment, such as academic achieve-
ment. Further, we did not investigate the possible differential
relationship between the two ADHD symptom axes (inatten-
tion versus hyperactivity/impulsivity) and neurocognitive
functioning, since this was beyond the scope of our paper.
However, this might be of relevance. For example, Rapport
et al. (2009) have suggested that increased activity levels aug-
ment arousal needed for working memory performance in all
children, and specifically in children with ADHD due to
chronic cortical underarousal (Rapport et al. 2009).
However, as the separate symptom axes are strongly interre-
lated and also strongly correlated to total symptom severity,
and no clear relationship was found between neurocognitive
functioning and ADHD total symptoms, it would be unex-
pected to find meaningful relat ionships between
neurocognitive functions and specific symptom axes.
Taken together, the present study provides insight into
the course of multiple neurocognitive domains in ADHD
affected and unaffected siblings compared to controls, and
studied how change in neurocognitive functioning is re-
lated to ADHD outcomes. Some neurocognitive functions
trended in the direction of, or fully caught-up, with nor-
mative performance, while other important neurocognitive
functions (i.e. verbal working memory, variability in
responding) remained impaired while symptoms im-
proved, and no clear association between neurocognitive
change and ADHD outcomes was found at all. Our find-
ings question the etiological link between neurocognitive
deficits and ADHD.
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